Related Party Transactions (Additional Information) (Details) |
3 Months Ended | 6 Months Ended | 8 Months Ended | 9 Months Ended | 12 Months Ended | |
|---|---|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2026
USD ($)
|
Jul. 03, 2026
USD ($)
|
Jun. 30, 2026
USD ($)
|
Dec. 31, 2025
USD ($)
|
Sep. 25, 2025
Agreement
|
|
| Related Party Transaction [Line Items] | ||||||
| Number of development agreements | Agreement | 3 | |||||
| Accrued liabilities | $ 200,000 | $ 200,000 | $ 200,000 | |||
| Adare Pharma Solutions [Member] | ||||||
| Related Party Transaction [Line Items] | ||||||
| Expenses expected to incur | 3,200,000 | |||||
| Expenses incurred | 400,000 | 700,000 | $ 34,000 | |||
| Prepayment of expenses | 200,000 | 200,000 | 200,000 | 200,000 | ||
| Research and development expense | 800,000 | |||||
| Dr. Slaoui [Member] | ||||||
| Related Party Transaction [Line Items] | ||||||
| Amounts payable | 8,250 | |||||
| Consulting fees incurred | 24,000 | 48,000 | $ 62,000 | 13,750 | ||
| Accrued liabilities | $ 21,000 | $ 21,000 | $ 21,000 | $ 5,500 |
| X | ||||||||||
- Definition Number of development agreements. No definition available.
|
| X | ||||||||||
- Definition Prepaid expenses related party. No definition available.
|
| X | ||||||||||
- Definition Related party consulting fee incurred. No definition available.
|
| X | ||||||||||
- Definition Related party transaction amounts payable. No definition available.
|
| X | ||||||||||
- Definition Related party transaction expenses expected to incur. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|